Healthcare

Miltenyi Biotec weighs local CGT manufacturing, eyes export potential

German biotech firm explores hospital-linked cell and gene therapy manufacturing in India while assessing long-term opportunities in regional CGT production, training and exports

Samsung Galaxy users can soon order medicines, book tests from Health app

Samsung introduces 'Find Care' feature inside the Health app, allowing medicine orders, lab test bookings and online doctor consultations through PharmEasy and Tata 1mg

Philips CEO Roy Jakobs hails India's potential as 'AI Powerhouse'

Jakobs said he believes India should be a global AI powerhouse, highlighting its strong software talent and 97 years of Philips' presence, positioning the country to lead AI development

Apollo Hospitals redraws medical tourism map as Bangladesh share dips

Apollo Hospitals offsets Bangladesh disruption with Africa and West Asia push, lifting international revenue 28% in Q3FY26 as Apollo 24/7 eyes breakeven by Q1FY27

Why Germany is turning to Indian nurses to fill growing workforce gap

Germany faces a shortage of up to 40,000 nurses as its ageing population strains hospitals, prompting a hiring push in India alongside new mobility and skills agreements

Out-of-pocket healthcare costs fell sharply over past decade: Nadda

Union Health Minister J P Nadda on Saturday said India has witnessed a substantial reduction in out-of-pocket expenditure on healthcare over the past decade, easing the financial burden on households, particularly among economically-vulnerable sections. He made these remarks while addressing the 8th convocation ceremony of Swami Rama Himalayan University in Dehradun. Highlighting the transformative strides made in India's health sector over the past 11 years, Nadda stated that the number of AIIMS has increased from 6 to 23, substantially expanding access to advanced tertiary healthcare services across the country. He further informed that institutional deliveries have risen to nearly 89 per cent, reflecting strengthened maternal healthcare systems. Emphasizing financial protection in healthcare, Nadda spoke about Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), which provides health cover of Rs 5 lakh per family. He stated that the scheme now benefits nearly 62 crore .

US adds 130,000 jobs in January, 2024 payrolls cut by nearly 900,000

US employers added a surprisingly strong 1,30,000 jobs last month, but government revisions cut 2024-2025 US payrolls by hundreds of thousands. The unemployment rate fell to 4.3 per cent, the Labour Department said Wednesday. The report included major revisions that reduced the number of jobs created last year to just 1,81,000, weakest since the pandemic year of 2020, and less than half the previously reported 5,84,000. The job market has been sluggish for months even though the economy is registering solid growth. But the January numbers came in stronger than the 75,000 economists had expected. Healthcare accounted for nearly 82,000, or more than 60 per cent, of last month's new jobs. Factories added 5,000, snapping a streak of 13 straight months of job losses. The federal government shed 34,000 jobs. Average hourly wages rose a solid 0.4 per cent from December to January. The unemployment rate fell from 4.4 per cent in December as the number of employed Americans rose and the n

FIIs pull ₹33,336 cr in Jan 2026, dump defensives, buy metals: PL Capital

Heavy selling in defensive and consumption-related industries like FMCG, healthcare, and consumer services drove the January outflows

India's single-specialty healthcare market to triple to over $12 bn by 2030

Report points to a structural shift in India's $54 billion healthcare market as focused, asset-light providers scale alongside large hospitals

Tariff reset lifts India's medical device pulse amid China+1 shift

US tariff cut lifts Indian medical devices; pharma steady, nutraceuticals seek clarity

What Budget 2026 means for common citizens

What does Budget 2026 mean for common citizens? This video explains the key announcements and how they impact daily expenses, taxes, savings, and household finances.

Menstrual health integral part of right to life and dignity, says SC

Court orders nationwide rollout of free menstrual hygiene facilities in schools, making the Union government's policy binding on all government and private institutions

Kidney stone myths busted: Beer, clear urine & what really works

Can beer flush out kidney stones? Does clear urine mean you’re safe? In this episode of our fact-check series, we bring to you a nephrologist's insights on common kidney stone myths and explain what t

Economic Survey 2026: Obesity fast becoming a public health challenge

Economic Survey flags rising lifestyle diseases and obesity in India, urging stricter regulation and warning labels on ultra-processed foods to curb health risks

Sagility slips 5% post Q3 results; analysts retain 'buy', check target

Sagility's profit after tax (PAT) grew 23 per cent year-on-year to ₹322.9 crore in Q3FY26 compared to ₹262.6 crore in the year-ago period

Budget 2026-27: Here are key challenges in the health care sector

As digital health gains pace, Budget expectations centre on higher spending, insurance expansion and a preventive-care shift to fix India's healthcare gaps

What are postbiotic supplements and do you really need them for your gut?

Postbiotics are beneficial compounds produced when gut bacteria, including probiotics, break down prebiotics. In other words, they are not live bacteria, but substances those bacteria produce

Medical emergencies drive urban Indians to personal loans, says study

Rising medical costs and insurance gaps are pushing more urban Indians to take personal loans for healthcare, with reliance highest in Tier-I cities, a Paisabazaar study shows

Pharma & healthcare funds: Easing valuations, rising insurance aid outlook

Price controls by the Indian regulator, USFDA actions, and concentration risk are key concerns

Dr Reddy's Q3 PAT down 14% Y-o-Y on low Lenalidomide sales in US

Dr Reddy's Laboratories reported a sharp fall in December-quarter profit as declining Lenalidomide sales in the US weighed on earnings, even as India revenues and branded businesses remained resilient